1. Home
  2. CVAC vs ACEL Comparison

CVAC vs ACEL Comparison

Compare CVAC & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • ACEL
  • Stock Information
  • Founded
  • CVAC 2000
  • ACEL 2009
  • Country
  • CVAC Germany
  • ACEL United States
  • Employees
  • CVAC N/A
  • ACEL N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • ACEL Services-Misc. Amusement & Recreation
  • Sector
  • CVAC Health Care
  • ACEL Consumer Discretionary
  • Exchange
  • CVAC Nasdaq
  • ACEL Nasdaq
  • Market Cap
  • CVAC 643.8M
  • ACEL 951.1M
  • IPO Year
  • CVAC 2020
  • ACEL N/A
  • Fundamental
  • Price
  • CVAC $2.82
  • ACEL $11.47
  • Analyst Decision
  • CVAC Hold
  • ACEL Strong Buy
  • Analyst Count
  • CVAC 3
  • ACEL 1
  • Target Price
  • CVAC $10.00
  • ACEL $16.00
  • AVG Volume (30 Days)
  • CVAC 399.6K
  • ACEL 145.7K
  • Earning Date
  • CVAC 11-12-2024
  • ACEL 10-30-2024
  • Dividend Yield
  • CVAC N/A
  • ACEL N/A
  • EPS Growth
  • CVAC N/A
  • ACEL N/A
  • EPS
  • CVAC N/A
  • ACEL 0.57
  • Revenue
  • CVAC $70,565,734.00
  • ACEL $1,195,795,000.00
  • Revenue This Year
  • CVAC $105.61
  • ACEL $5.60
  • Revenue Next Year
  • CVAC N/A
  • ACEL $3.64
  • P/E Ratio
  • CVAC N/A
  • ACEL $20.10
  • Revenue Growth
  • CVAC 75.11
  • ACEL 5.74
  • 52 Week Low
  • CVAC $2.22
  • ACEL $9.37
  • 52 Week High
  • CVAC $6.30
  • ACEL $12.61
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 38.84
  • ACEL 49.12
  • Support Level
  • CVAC $2.79
  • ACEL $11.17
  • Resistance Level
  • CVAC $2.89
  • ACEL $11.61
  • Average True Range (ATR)
  • CVAC 0.11
  • ACEL 0.17
  • MACD
  • CVAC -0.01
  • ACEL -0.01
  • Stochastic Oscillator
  • CVAC 19.44
  • ACEL 57.69

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About ACEL Accel Entertainment Inc.

Accel Entertainment Inc is a distributed gaming operator in the United States. It is engaged in the installation, maintenance, and operation of video gaming terminals. The company offers products to restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. It operates slot machines and amusement equipment. The company generates a majority of its revenue from net gaming. Net gaming revenue represents net cash received from gaming activities, which is the difference between gaming wins and losses. Net gaming revenue includes the amount earned by location partners and is recognized at the time of gaming play.

Share on Social Networks: